# A Study to Characterize Pharmacokinetics (PK) and Pharmacodynamics (PD) of LUSEDRA® Administered as Continuous Infusion or Bolus Compared With Continuous Infusion of Propofol Injectable Emulsion

> **NCT01308541** · PHASE1 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 20 (actual)

## Conditions studied

- Monitored Anesthesia Care

## Interventions

- **DRUG:** arm 1
- **DRUG:** LUSEDRA
- **DRUG:** Propofol (arm 3)

## Key facts

- **NCT ID:** NCT01308541
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2015-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01308541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01308541, "A Study to Characterize Pharmacokinetics (PK) and Pharmacodynamics (PD) of LUSEDRA® Administered as Continuous Infusion or Bolus Compared With Continuous Infusion of Propofol Injectable Emulsion". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01308541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*